Ş. Takci Et Al. , "The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage," Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4, pp.1008-1012, 2022
Takci, Ş. Et Al. 2022. The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage. Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4 , 1008-1012.
Takci, Ş., KORKMAZ TOYGAR, A., YİĞİT, Ş., & Yurdakök, M., (2022). The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage. Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4, 1008-1012.
Takci, Şahin Et Al. "The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage," Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4, 1008-1012, 2022
Takci, Şahin Et Al. "The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage." Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4, pp.1008-1012, 2022
Takci, Ş. Et Al. (2022) . "The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage." Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.4, pp.1008-1012.
@article{article, author={Şahin Takci Et Al. }, title={The effects of maternal anticoagulant therapy on cord blood levels of VEGF-A and soluble Flt-1 in women with recurrent miscarriage}, journal={Journal of Experimental and Clinical Medicine (Turkey)}, year=2022, pages={1008-1012} }